D. E. Shaw & Co., Inc. Ardelyx, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 15,299 shares of ARDX stock, worth $79,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,299

Holding current value

$79,095

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.28 - $7.57 $24,192 - $34,685	4,582 Added 42.75%	15,299 $105,000
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.31 $63,123 - $99,775	10,717 New	10,717 $79,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $67,003 - $153,714	-131,380 Reduced 20.09%	522,668 $308,000
Q1 2022 May 16, 2022	BUY	$0.65 - $1.18 $346,627 - $629,262	533,273 Added 441.54%	654,048 $700,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $700,373 - $1.38 Million	-814,388 Reduced 87.09%	120,775 $133,000
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $804,501 - $5.18 Million	633,466 Added 209.97%	935,163 $1.23 Million
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $1.02 Million - $1.4 Million	-155,792 Reduced 34.05%	301,697 $2.29 Million
Q1 2021 May 17, 2021	SELL	$6.1 - $7.69 $2.38 Million - $3.01 Million	-390,775 Reduced 46.07%	457,489 $3.03 Million
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $308,110 - $433,185	-61,012 Reduced 6.71%	848,264 $5.49 Million
Q3 2020 Nov 16, 2020	BUY	$5.25 - $7.08 $576,775 - $777,822	109,862 Added 13.74%	909,276 $4.77 Million
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $660,574 - $997,627	123,012 Added 18.19%	799,414 $5.53 Million
Q1 2020 May 15, 2020	SELL	$4.35 - $8.79 $1.15 Million - $2.33 Million	-265,147 Reduced 28.16%	676,402 $3.85 Million
Q4 2019 Feb 14, 2020	SELL	$4.23 - $8.29 $1.27 Million - $2.49 Million	-300,669 Reduced 24.2%	941,549 $7.07 Million
Q3 2019 Nov 14, 2019	BUY	$2.15 - $6.28 $930,395 - $2.72 Million	432,742 Added 53.46%	1,242,218 $5.84 Million
Q2 2019 Aug 14, 2019	BUY	$2.49 - $3.73 $278,787 - $417,621	111,963 Added 16.05%	809,476 $2.18 Million
Q1 2019 May 15, 2019	BUY	$1.88 - $3.35 $346,927 - $618,195	184,536 Added 35.97%	697,513 $1.95 Million
Q4 2018 Feb 14, 2019	BUY	$1.66 - $4.16 $341,657 - $856,202	205,818 Added 67.01%	512,977 $918,000
Q3 2018 Nov 14, 2018	BUY	$3.75 - $4.65 $273,915 - $339,654	73,044 Added 31.2%	307,159 $1.34 Million
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $706,555 - $1.11 Million	190,961 Added 442.51%	234,115 $866,000
Q1 2018 May 15, 2018	SELL	$5.05 - $7.9 $128,941 - $201,710	-25,533 Reduced 37.17%	43,154 $218,000
Q4 2017 Feb 14, 2018	SELL	$4.85 - $7.8 $820,935 - $1.32 Million	-169,265 Reduced 71.13%	68,687 $453,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.7 $1.04 Million - $1.36 Million	237,952	237,952 $1.33 Million

Others Institutions Holding ARDX

# of Institutions

218

Shares Held

141M

Call Options Held

1.08M

Put Options Held

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account